Jul 8, 2022 · Drug repositioning represents an efficient strategy for discovering new applications of existing drugs, due to its outstanding advantages over ...
Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis.
ArticlePDF Available. Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment ... drug discovery approach. Cancer is characterized ...
Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis.
Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis.
Jul 8, 2022 · Identification of Novel Drugs Targeting Cell Cycle Regulators for ... Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics ...
Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis.
Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis.
Oct 21, 2021 · Therefore, repurposing of known drugs is a feasible drug development strategy. In the present study, by focusing directly on EOC datasets, we ...
Missing: Serous | Show results with:Serous
People also ask
What drugs are repurposing in high-grade serous ovarian cancer?
What is the prognosis for HGSOC?
How do you treat high-grade serous carcinoma of the ovaries?
What are the symptoms of HGSOC?
Article "Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics ...